New Biotech Institute To Develop Organs For Transplant

The Advanced Regenerative Manufacturing Institute (ARMI) has just opened in Manchester and has the potential to transform the region into a flourishing tech hub for healthcare. The institute will work to develop transplant organs and tissues grown from scratch for soldiers and veterans who have lost limbs in combat, as well for as other patients, such as those with renal failure.

BioFabUSA is ARMI’s first large project, a public-private partnership designed to build the technologies necessary to create human organ factories. The goal is to one day mass-produce human organs for those in need of a transplant.

President and CEO of the Greater Manchester Chamber, Michael Skelton, believes that the project could be transformative for the city. Jerry McGinn from the Department of Defense commented that “Many of the challenges we face in the department are in areas that are either adjacent to the battlefield or not on the battlefield itself and that’s why this institute is so important.”

ARMI will be led by DEKA Research and Development Corp, Dartmouth-Hitchcock and the University of New Hampshire. The institute will bring jobs and draw talented researchers to work on the cutting-edge technology.

Founder Dean Kamen said that “This is one of those rare places where the technology that we’re developing is one that is going to give you a better outcome, but it also lowers the cost,” referring to the replacement of a failing kidney, where the patient would no longer need dialysis.

The Department of Defense will invest $80 million into the project over five years, with another $200 million coming from private investors, including universities and medical research institutions.

Governor Chris Sununu said that the best thing that New Hampshire can do is provide an atmosphere that makes it easy for businesses to come in and partner, “Because that’s what this is: a public-private partnership.”

Advanced Solutions are already considering moving their life sciences lab to New Hampshire. CEO Michael Golway presented the BioAssemblyBot (BAB) at ARMI, which is a 3D printer that has the ability to build tissue.

Companies creating new knowledge on a global scale can apply for the federal and New Hampshire R&D tax credit. Companies who are unsure about whether their projects qualify can contact Swanson Reed R&D Tax Advisors to assess their eligibility.

Recent Posts